The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Pfizer naming Thomas Byrne .

Filed returns
12
match these filters
Matching filed returns per period 0 1 2 3 5 Jan–Apr 2021: 2 filed returns May–Aug 2021: 2 filed returns Sep–Dec 2021: 3 filed returns Sep–Dec 2022: 1 filed returns Sep–Dec 2025: 1 filed returns Jan–Apr 2026: 3 filed returns 2021 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Jan–Apr 2026 Pfizer Health Ireland's medicine reimbursement system and access to new medicine (Matters involving public funds) 2 On lobbying.ie
Jan–Apr 2026 Pfizer EU Affairs Ireland’s priorities for the 2026 Presidency of the Council of the European Union, including issues related to life sciences competitiveness, pharmaceutical manufacturing, and EU-level health emergency preparedness (Public policy or programme) 3 On lobbying.ie
Jan–Apr 2026 Pfizer Health Expansion of the National Immunisation Programme to include RSV vaccination for older adults (Public policy or programme) 16 On lobbying.ie
Sep–Dec 2025 Pfizer EU Affairs Ireland priorities for the Presidency of the Council of the European Union (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2022 Pfizer EU Affairs EC HERA contract in relation to Pfizer COVID-19 vaccine (Matters involving public funds) 5 On lobbying.ie
Sep–Dec 2021 Pfizer Economic Development and Industry Proposed COVID-19 Trips waiver (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2021 Pfizer Health COVID-19 vaccination programme (Public policy or programme) 5 On lobbying.ie
Sep–Dec 2021 Pfizer Health Pfizer has an investigational COVID-19 treatment, a protease inhibitor which subject to clinical trials and regulatory approvals could play a complementary role to vaccination in helping to manage COVID-19 (Matters involving public funds) 5 On lobbying.ie
May–Aug 2021 Pfizer EU Affairs Pfizer has an investigational COVID-19 treatment, a protease inhibitor which subject to clinical trials and regulatory approvals could play a complementary role to vaccination in helping to manage COVID-19 (Public policy or programme) 1 On lobbying.ie
May–Aug 2021 Pfizer Health Supply of Pfizer COVID-19 vaccine including Ireland volumes; expansion of manufacturing capacity to include Grange Castle site and Pfizer colleague vaccination programme (Public policy or programme) 8 On lobbying.ie
Jan–Apr 2021 Pfizer EU Affairs Highlight Pfizer concerns re proposed EU vaccine export restrictions and how this could impact Pfizer's ability to manufacture the COVID 19 vaccine and provide supply globally (Public policy or programme) 5 On lobbying.ie
Jan–Apr 2021 Pfizer Health Updates in relation to Pfizer COVID 19 vaccine including global production, Ireland volumes and company colleague vaccination programme (Matters involving public funds) 10 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 6 50.0%
EU Affairs 5 41.7%
Economic Development and Industry 1 8.3%